Fibromatosis, relaxin and progesterone
Barousse, A.P.
Medicina 38(2): 215-216
1978
ISSN/ISBN: 0025-7680 PMID: 682940 Document Number: 138285
Document emailed within 1 workday
Related Documents
Lanari, A.; Molinas, F.C.; Castro Ríos, M.; Paz, R.A. 1978: Effective treatment of several types of fibromatosis with progesterone. Fibrous mediastinitis, desmoid tumors, paraneoplastic fibrosis Medicina 38(2): 123-132Barrière, H.; Litoux, P.; Bureau BWelin, J.; Stalder, J.F. 1975: Fibromatosis in children. An attempt at classification, apropos of a case of extensive ossifying fibromatosis Annales de Dermatologie et de Syphiligraphie 102(1): 5-20
Roche, J.F.; Gosling, J.P. 1977: Control of estrus and progesterone levels in heifers given intravaginal progesterone coils and injections of progesterone and estrogen Journal of Animal Science 44(6): 1026-1029
Anonymous 2000: Progestins, Progesterone Receptor Modulators, and Progesterone Antagonists. Progesterone, progestins and antiprogestins in the next millennium, Jerusalem, Israel, 31 August-3 September, 1999 Steroids 65(10/11): 543-850
Choe, J.K.; Check, J.H.; Nowroozi, K.; Benveniste, R.; Barnea, E.R. 1992: Serum progesterone and 17-hydroxyprogesterone in the diagnosis of ectopic pregnancies and the value of progesterone replacement in intrauterine pregnancies when serum progesterone levels are low Gynecologic and Obstetric Investigation 34(3): 133-138
Abramchenko, V.V. 1988: Relaxin and pregnancy Akusherstvo i Ginekologiia 4: 9-11
Rocha, F.G.; Horton, J.S.; Bryant-Greenwood, G.D. 2013: Relaxin and preterm birth Italian Journal of Anatomy and Embryology 118(1 Suppl): 21-22
Toivonen, J. 1980: Pituitary and gonadal function during the use of progesterone- or progesterone-estradiol-releasing vaginal rings International Journal of Fertility 25(2): 106-111
Richardson, A.P.; Kim, J.B.; Barnard, G.J.; Collins, W.P.; McCapra, F. 1985: Chemiluminescence immunoassay of plasma progesterone, with progesterone-acridinium ester used as the labeled antigen Clinical Chemistry 31(10): 1664-1668
Dragonas, C.; Maltaris, T.; Binder, H.; Kat, M.; Mueller, A.; Cupisti, S.; Hoffmann, I.; Beckmann, M.W.; Dittrich, R. 2007: Progesterone bioavailability with a progesterone-releasing silicone vaginal ring in IVF candidates European Journal of Medical Research 12(6): 264-267
Wolf, H.; Egert, D.; Maass, H. 1973: Progesterone binding protein and the influence of corticosteroids on the uptake of progesterone by the rat uterus Acta Endocrinologica. Supplementum 173: 68
Pouly, J.L.; Bassil, S.; Frydman, R.; Hédon, B.; Nicollet, B.; Prada, Y.; Antoine, J.M.; Zambrano, R.; Donnez, J. 1997: Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone Contraception Fertilite Sexualite 25(7-8): 596-601
Eremin, A.N.; Metelitsa, D.I. 1989: Catalytic activity of conjugates of peroxidase with progesterone in aqueous and micellar media in the presence of antibodies against progesterone Bioorganicheskaia Khimiia 15(10): 1326-1333
Gu, X.; Wang, D.; Tao, L.; Jin, H.; Zhao, Y.; Wang, Y. 2015: Serum relaxin in cervical incompetence patients Zhonghua Yi Xue Za Zhi 95(35): 2817-2820
Wright, L.C.; Anderson, R.R. 1982: Effect of relaxin on mammary growth in the hypophysectomized rat Advances in Experimental Medicine and Biology 143: 341-355
Bagnell, C.A.; Zhang, Q.; Downey, B.; Ainsworth, L. 1993: Sources and biological actions of relaxin in pigs Journal of Reproduction and Fertility. Suppl 48: 127-138
Jockenhövel, F.; Peterson, M.A.; Johnston, P.D.; Swerdloff, R.S. 1991: Directly iodinated rat relaxin as a tracer for use in radioimmunoassays European Journal of Clinical Chemistry and Clinical Biochemistry 29(1): 71-75
Keltz, M.D.; Stein, D.E.; Berin, I.; Skorupski, J. 2012: Elevated progesterone-to-estradiol ratio versus serum progesterone alone for predicting poor cycle outcome with in vitro fertilization Journal of Reproductive Medicine 57(1-2): 9-12
Wu, Z.; Wu, H.; Sun, S.; Wu, H.; Shi, W.; Song, J.; Liu, J.; Zhang, Y.; Bian, F.; Jia, P.; Hou, Y. 2020: Progesterone attenuates Aβ25-35-induced neuronal toxicity by activating the Ras signalling pathway through progesterone receptor membrane component 1 Life Sciences 253: 117360
Allen, W.M.; Ehrenstein, M. 1944: 10-Nor-Progesterone, a Physiologically Active Lower Homolog of Progesterone Science 100(2594): 251-252